Name: Addiction 2026
Start: 2026-05-14
End: 2026-05-16
Location: Czech Republic

Conference Information

Welcome Message

Greetings and a warm welcome to the 9th World Congress on Addiction Medicine and Psychiatry, set in the beautiful city of Prague, Czech Republic, on May 14–15, 2026.

This congress highlights the evolving landscape of addiction and mental health under the theme

“Transforming Lives with Breakthroughs in Mind and Medicine”.

Here, we focus on how new scientific insights and clinical practices can reshape treatment pathways, support recovery, and strengthen mental well-being across communities.

As we gather with shared purpose, let us combine knowledge, experience, and innovation to move from challenges to meaningful change—turning every breakthrough into a step toward a healthier future.

Together, we move forward with hope, clarity, and commitment.

Warm Regards
Manina Rachel
Organizing Committee |Addiction 2026
Email: addictioncongress@pulsusforums.com
Contact: +447389644903

About Addiction 2026

The Addiction 2026 convenes on May 14–15, 2026, in Prague, Czech Republic, uniting global specialists, clinical professionals, researchers, and thought leaders committed to advancing the fields of mental health and addiction science.

Under the guiding theme “Transforming Lives with Breakthroughs in Mind and Medicine,” this congress provides a dynamic environment for presenting novel findings, examining emerging therapeutic strategies, and addressing the complex challenges shaping modern psychiatric and addiction care. The meeting is designed to strengthen interdisciplinary collaboration, expand scientific understanding, and contribute to the worldwide effort to enhance patient care, support long-term recovery, and elevate standards of practice across diverse healthcare settings.

Main Focus of the Conference:

The main focus of this congress is to bring forward innovative ideas and evidence-based approaches to understanding, preventing, and treating addiction and mental health disorders.
Key priorities include:

Exploring new research in addiction science
Advancing mental health diagnostics and treatment models
Understanding brain and behavior connections
Introducing modern therapeutic strategies and technologies
Strengthening recovery and rehabilitation systems
Encouraging global dialogue and multidisciplinary collaboration

The conference aims to turn scientific progress into real-world solutions that improve patient lives and strengthen mental health care worldwide.

Who Will Benefit From the Conference?

The Addiction 2026 is designed for anyone working to improve mental health and addiction care. This includes:

Addiction medicine specialists
Psychiatrists and psychologists
Mental health professionals
Researchers and scientists
Rehabilitation and recovery experts
Public health professionals
Nurses, social workers, and counselors
Students and emerging professionals
Policymakers and healthcare leaders

Participants will benefit from new knowledge, practical insights, global perspectives, and opportunities for professional collaboration.

Sessions

Session 1: Addiction Medicine

Addiction Medicine focuses on the prevention, diagnosis, and treatment of substance-use disorders, behavioral addictions, and co-occurring medical conditions. This session will explore evidence-based treatment models, withdrawal management, relapse prevention, and emerging therapeutic innovations. Experts will share insights on improving patient outcomes and strengthening clinical frameworks in addiction care.

Topics:

1.1 Substance Use Disorder Management

1.2 Medication-Assisted Treatment (MAT)

1.3 Relapse Prevention Strategies

1.4 Withdrawal Management Approaches

1.5 Integrated Addiction Treatment Models

Associated Societies:

Associated Journals & Conferences:

Session 2: Psychiatry

Psychiatry plays a crucial role in understanding, diagnosing, and treating mental, emotional, and behavioral disorders. This session will highlight the latest advancements in psychiatric evaluation, therapeutic approaches, and multidisciplinary care for individuals with complex mental health needs.

Topics:

2.1 Psychiatric Assessment & Diagnosis

2.2 Neuropsychiatric Disorders

2.3 Psychopharmacological Treatments

2.4 Psychiatric Rehabilitation

2.5 Integrative Psychiatry Approaches

Associated Societies:

Associated Journals & Conferences:

Session 3: Behavioral Addiction

Behavioral Addiction explores non-substance-related compulsive behaviors such as gaming, gambling, internet overuse, and shopping addiction. This session will emphasize clinical characteristics, neurobiological mechanisms, diagnostic frameworks, and emerging therapeutic interventions for managing these disorders.

Topics:

3.1 Internet & Gaming Addiction

3.2 Gambling Disorder

3.3 Compulsive Shopping

3.4 Smartphone

3.5 Behavioral Addiction Therapy Models

Associated Societies:

Associated Journals & Conferences:

Session 4: Anxiety and Depression

Anxiety and Depression represent the most common mental health disorders globally. This session will examine diagnostic tools, neurobiological pathways, innovative treatment options, and community-based strategies to enhance mental health resilience and patient recovery.

Topics:

4.1 Major Depressive Disorder

4.2 Generalized Anxiety Disorder

4.3 Cognitive Behavioral Therapy Approaches

4.4 Neurochemical Imbalance & Mood Disorders

4.5 Holistic & Lifestyle-Based Interventions

Associated Societies:

Associated Journals & Conferences:

Session 5: Neuroscience of Addiction

Neuroscience of Addiction focuses on understanding how addictive substances and behaviors alter brain circuits, reward pathways, and decision-making processes. This session will present cutting-edge research using neuroimaging, biomarkers, and neurobiological models to develop targeted treatments.

Topics:

5.1 Brain Reward Pathways

5.2 Neuroimaging in Addiction

5.3 Neuroplasticity & Craving

5.4 Genetic & Epigenetic Factors

5.5 Neurocognitive Impairment in Addiction

Associated Societies:

Associated Journals & Conferences:

Session 6: Adolescent Addiction

Adolescent Addiction examines how substance use and behavioral dependencies develop among teenagers, focusing on early exposure, peer influence, emotional challenges, and neurodevelopmental vulnerability. This session highlights screening tools, school-based interventions, counseling models, and preventive strategies tailored to youth populations.

Topics:

6.1 Early-Onset Substance Use

6.2 Adolescent Brain Development & Risk

6.3 School-Based Prevention Programs

6.4 Family and Community Interventions

6.5 Digital Behavior & Teen Addiction

Associated Societies:

Associated Journals & Conferences:

Session 7: Drug Addiction

Drug Addiction focuses on the impact of opioids, stimulants, cannabis, and emerging psychoactive substances on health, behavior, and social well-being. This session will discuss treatment protocols, harm-reduction policies, detoxification approaches, and evidence-based programs for managing chronic dependence.

Topics:

7.1 Opioid Use Disorder

7.2 Stimulant & Cocaine Addiction

7.3 Prescription Drug Misuse

7.4 Novel Psychoactive Substances (NPS)

7.5 Detoxification & Long-Term Treatment

Associated Societies:

Associated Journals & Conferences:

Session 8: Youth Addiction

Youth Addiction focuses on individuals aged 18–25, a critical phase marked by emotional transitions, academic pressure, and exposure to risky environments. This session explores substance use patterns, stress-related behaviors, campus mental health programs, and community rehabilitation frameworks designed for young adults.

Topics:

8.1 College & University Substance Use Trends

8.2 Stress, Identity & Addiction

8.3 Peer Pressure & Social Influences

8.4 Young Adult Rehabilitation Models

8.5 Early Screening Techniques

Associated Societies:

Associated Journals & Conferences:

Session 9: Alcohol Addiction

Alcohol Addiction remains one of the most prevalent and socially challenging forms of addiction. This session will focus on the biological, psychological, and social dimensions of alcohol dependence, including detox management, relapse prevention, long-term rehabilitation, and public health policy frameworks.

Topics:

9.1 Alcohol Use Disorder (AUD)

9.2 Behavioral and Pharmacological Treatments

9.3 Alcohol Withdrawal Management

9.4 Alcohol-Related Liver Disease

9.5 Community-Based Alcohol Rehabilitation

Associated Societies:

Associated Journals & Conferences:

Session 10: Food Addiction

Food Addiction explores compulsive eating behaviors, emotional eating patterns, and the neurobiological mechanisms driving dependence on high-fat, high-sugar foods. This session will present clinical guidelines, behavioral therapies, nutritional interventions, and research linking food addiction to obesity and mental health disorders.

Topics:

10.1 Compulsive & Emotional Eating

10.2 Neurobiology of Food Cravings

10.3 Eating Disorders & Mental Health Link

10.4 Obesity and Addiction Pathways

10.5 Nutritional & Behavioral Interventions

Associated Societies:

Associated Journals & Conferences:

Session 11: Mental Health

Mental Health is a critical pillar in understanding overall well-being, addressing conditions that affect emotions, behavior, and cognitive functioning. This session explores global mental health challenges, early diagnosis, integrative care models, and community-based approaches. Experts will discuss innovative strategies to strengthen resilience, reduce stigma, and improve access to mental healthcare.

Topics:

11.1 Global Mental Health Challenges

11.2 Early Detection & Screening Tools

11.3 Community Mental Health Interventions

11.4 Integrative & Holistic Care Approaches

11.5 Mental Health Policy & Advocacy

Associated Societies:

Associated Journals & Conferences:

Session 12: Psychopharmacology

Psychopharmacology examines the effects of medications on mood, behavior, and neurological function. This session focuses on advancements in psychiatric drug development, personalized medicine, drug interactions, and innovative therapies aimed at improving treatment outcomes in addiction and mental health disorders.

Topics:

12.1 Antidepressants & Antipsychotics

12.2 Pharmacotherapy for Addiction

12.3 Personalized Psychiatry

12.4 Drug Interactions & Safety

12.5 Novel Therapeutic Agents

Associated Societies:

Associated Journals & Conferences:

Session 13: Psychiatry Disorder

Psychiatry Disorder focuses on the diagnosis and management of a wide spectrum of mental conditions including mood disorders, psychotic disorders, personality disorders, and neurodevelopmental issues. This session highlights modern diagnostic tools, therapeutic developments, and case-based discussions to improve clinical decision-making.

Topics:

13.1 Mood & Bipolar Disorders

13.2 Schizophrenia Spectrum Disorders

13.3 Personality Disorders

13.4 Neurodevelopmental Disorders

13.5 Evidence-Based Treatment Approaches

Associated Societies:

Associated Journals & Conferences:

Session 14: Psychological Trauma

Psychological Trauma examines the emotional and cognitive impact of distressing life events, including abuse, violence, accidents, and long-term stress. This session covers trauma-informed care, PTSD management, neurobiological effects of trauma, and therapeutic innovations that support recovery and resilience.

Topics:

14.1 Post-Traumatic Stress Disorder (PTSD)

14.2 Trauma-Informed Care Models

14.3 Childhood Trauma & Long-Term Effects

14.4 Neurobiology of Trauma

14.5 Trauma Counseling & EMDR Therapy

Associated Societies:

Associated Journals & Conferences:

Session 15: Clinical Psychiatry

Clinical Psychiatry focuses on the practical application of psychiatric principles in diagnosing and treating patients. This session highlights patient-centered care, advanced clinical assessment methods, therapeutic planning, and multidisciplinary teamwork to improve mental healthcare delivery.

Topics:

15.1 Clinical Assessment & Diagnosis

15.2 Evidence-Based Treatment Planning

15.3 Integrated Care Pathways

15.4 Psychiatric Emergency Management

15.5 Clinical Case Discussions

Associated Societies:

Associated Journals & Conferences:

Session 16: Geriatric Psychiatry

Geriatric Psychiatry focuses on mental health conditions affecting older adults, including dementia, late-life depression, anxiety, and substance misuse. This session highlights diagnostic challenges, cognitive assessments, caregiver support models, and innovative therapies designed to enhance quality of life for the aging population.

Topics:

16.1 Dementia & Cognitive Decline

16.2 Late-Life Depression

16.3 Anxiety Disorders in Older Adults

16.4 Substance Use in the Elderly

16.5 Geriatric Behavioral Interventions

Associated Societies:

Associated Journals & Conferences:

Session 17: Neurotoxicology

Neurotoxicology focuses on the harmful effects of chemicals, drugs, toxins, and environmental exposures on the nervous system. This session addresses mechanisms of neurotoxicity, long-term effects of drug abuse, biomarker discovery, and protective strategies to reduce neurological damage.

Topics:

17.1 Drug-Induced Neurotoxicity

17.2 Environmental Toxins & Brain Health

17.3 Neurotoxic Mechanisms & Pathways

17.4 Biomarkers of Neurotoxicity

17.5 Prevention & Neuroprotection Strategies

Associated Societies:

Associated Journals & Conferences:

Session 18: Psychotherapy & Counseling

Psychotherapy & Counseling explores a range of therapeutic approaches used to treat mental health conditions, addiction, trauma, and behavioral disorders. This session highlights evidence-based therapies, counseling frameworks, and innovative digital therapy tools.

Topics:

18.1 Cognitive Behavioral Therapy (CBT)

18.2 Dialectical Behavior Therapy (DBT)

18.3 Trauma-Focused Therapy

18.4 Group & Family Counseling

18.5 Teletherapy & Digital Counseling Tools

Associated Societies:

Associated Journals & Conferences:

Session 19: Public Health & Harm Reduction

Public Health & Harm Reduction focuses on strategies to minimize the negative health, social, and legal impacts associated with substance use. This session highlights policy frameworks, community-based programs, safe-use strategies, and evidence-based harm-reduction models adopted globally.

Topics:

19.1 Overdose Prevention Programs

19.2 Safe Injection & Consumption Sites

19.3 Community Harm Reduction Strategies

19.4 Public Health Policy & Addiction

19.5 Global Substance Use Surveillance

Associated Societies:

Associated Journals & Conferences:

Session 20: Digital & AI in Addiction Care

Digital & AI in Addiction Care explores how artificial intelligence, machine learning, telemedicine, and digital platforms are transforming addiction diagnosis, treatment, and monitoring. This session introduces innovative tools, predictive models, virtual therapy systems, and data-driven approaches shaping the future of addiction medicine.

Topics:

20.1 AI Tools for Addiction Screening

20.2 Telemedicine in Addiction Management

20.3 Predictive Analytics for Relapse Prevention

20.4 Mobile Apps & Digital Therapeutics

20.5 Virtual Reality for Behavioral Therapy

Associated Societies:

Associated Journals & Conferences:

Market Analysis

Market Analysis: Addiction Medicine & Psychiatry

Global Market Growth Overview

2015–2020: Strong Awareness Phase

Growing global awareness of substance abuse and mental health disorders.
Rapid rise in rehabilitation centers, psychiatric services, and addiction treatment facilities.
Increase in alcohol and drug dependency cases boosted demand for therapy, counselling, detox services, and behavioural treatments.
Estimated annual growth rate: 5%–7% (global mental health and addiction treatment market combined).

2020–2025: Pandemic-Driven Demand Surge

COVID-19 created a sharp increase in anxiety, depression, alcohol misuse, and prescription drug abuse.
Telepsychiatry and online addiction support services expanded worldwide.
Governments invested heavily in mental health programs.
Market growth accelerated to around 7%–9% annually.

2025–2030: Technology + Digital Recovery Era

AI-based Addiction 2026 monitoring systems, digital therapeutics, and app-based therapy predicted to lead the market.
Personalized addiction treatment using genetics, biomarkers, and neuropsychiatric tools becomes mainstream.
Europe (including Czech Republic) is expected to be a major hub for research, rehabilitation tourism, and clinical psychiatry training.
Expected annual growth: 8%–10%.

Europe & Czech Republic Outlook

Europe has one of the highest investments in mental health programs and rehabilitation infrastructure.
Prague is emerging as a research-friendly, cost-effective center for psychiatric sciences and addiction medicine.
Rise in substance abuse (alcohol, opioids, synthetic drugs) in Central Europe increases demand for:
- psychiatrists
- addiction specialists
- rehabilitation programs
- research collaborations
- preventive care initiatives

By 2030, Europe is projected to hold over 30% of the global addiction treatment market share.

Why This Market Is Relevant to the 2026 Prague Conference

Increasing global focus on addiction prevention and mental health resilience.
Strong scientific demand for new treatments, behavioural therapies, and digital tools.
Expanding funding for psychiatry research across Europe.
Greater need for international collaboration among clinicians, researchers, NGOs, and mental health policymakers.

9th World Congress on
Addiction Medicine and Psychiatry

Quick Links

Theme: Transforming Lives with Breakthroughs in Mind and Medicine

Conference Information

Welcome Message

About Addiction 2026

Sessions

Market Analysis